Beam Therapeutics Total Non Current Liabilities 2011-2025 | BEAM

Annual Total Non Current Liabilities Beam Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	26 M	7.4 M	20 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
26 M	20 K	11.1 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.78	-0.31 %	$ 793 M	Canada
Aclaris Therapeutics ACRS	5.95 M	$ 3.03	-0.49 %	$ 234 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	2.21 M	$ 1.15	-1.71 %	$ 6.27 M	China
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	106 M	-	-	$ 10.1 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Ascendis Pharma A/S ASND	101 M	$ 209.39	-1.61 %	$ 5 B	Danmark
Aptevo Therapeutics APVO	5 M	$ 0.6	-35.8 %	$ 166 K	USA
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.12	0.81 %	$ 7.51 B	Australia
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
BioVie BIVI	62.5 K	$ 1.2	-5.51 %	$ 1.77 M	USA
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
AVROBIO AVRO	276 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	1.63 M	$ 0.22	24.46 %	$ 479 M	Israel
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	23.6 M	-	-15.15 %	$ 60.3 M	Britain
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
BioNTech SE BNTX	341 M	$ 94.72	-0.33 %	$ 27.2 B	Germany
Amphastar Pharmaceuticals AMPH	69.4 M	$ 27.09	1.04 %	$ 1.31 B	USA
BeiGene, Ltd. BGNE	374 M	-	0.49 %	$ 251 B	Cayman-islands
Anika Therapeutics ANIK	26.1 M	$ 9.6	1.27 %	$ 141 M	USA
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	219 M	-	-	$ 546 M	USA
Arena Pharmaceuticals ARNA	52.2 M	-	-6.81 %	$ 3.04 B	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Axon Enterprise AXON	107 M	$ 584.81	-1.07 %	$ 44.3 B	USA
Cellectar Biosciences CLRB	422 K	$ 2.53	-8.33 %	$ 30.9 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	42.1 M	$ 2.44	-3.56 %	$ 15.3 M	USA
AstraZeneca PLC AZN	30.8 B	$ 92.79	0.37 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Catalyst Biosciences CBIO	981 K	$ 12.33	-0.29 %	$ 812 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
Celldex Therapeutics CLDX	17.3 M	$ 26.29	-2.01 %	$ 1.69 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	802 M	$ 11.07	2.45 %	$ 716 M	USA
Biogen BIIB	9.03 B	$ 176.45	0.07 %	$ 25.7 B	USA
Cerevel Therapeutics Holdings CERE	4.4 M	-	-	$ 7.29 B	USA